Anna Perdrix Rosell | |
---|---|
Alma mater |
|
Known for | Developmental biology, Organoids |
Awards | Future Leaders in Cancer Research Prize, Cancer Research UK |
Scientific career | |
Fields | Drug delivery, Tumour growth |
Institutions |
|
Anna Perdrix Rosell is a Spanish scientist who completed her PhD[when?] in cancer cell signalling at the Francis Crick Institute in London. She co-founded a biotech start-up, which helped her get onto the Forbes 30 under 30 list in 2018.[1][2]